Deploy the world's most trusted ICH E6(R3) GCP Training Platform to ensure your clinical investigators, site staff, and CROs are fully compliant with the latest Risk-Based Quality Management (RBQM) guidelines.
The transition from R2 to R3 emphasizes data governance, proportionality, and RBQM. Transitioning requires a dedicated ICH E6(R3) GCP Training Platform to prevent critical audit findings and clinical trial delays.
R3 mandates Risk-Based Quality Management. Old training systems fail to educate site staff on proportional risk mitigation, leaving studies exposed.
Regulatory agencies demand proof that sponsors maintain oversight. Disconnected paper certificates lead to FDA Form 483s and EMA findings.
With the rise of decentralized trials (DCTs), ensuring investigators understand ALCOA++ principles is impossible without modernized training tracks.
Every module in our ICH E6(R3) GCP Training Platform is mapped directly to the new regulatory principles, ensuring your site personnel are inspection-ready.
Eliminate redundant training. Our certificates are universally recognized, allowing investigators to onboard to new protocols 60% faster.
Secure biometric electronic signatures and immutable audit logs ensure flawless compliance during regulatory inspections.
Combine baseline E6(R3) training with your specific study protocols, Investigator Brochures (IB), and decentralized trial technologies.
Managing training across hundreds of global investigator sites is complex. With our ICH E6(R3) GCP Training Platform, sponsors gain real-time visibility into site readiness, expiring certificates, and protocol amendments.
Ideal for Phase 1/2 studies with limited sites requiring strict R3 baseline training.
For large, multi-national trials needing complex protocol and amendment tracking.
For global CROs managing extensive portfolios and demanding unified data governance.
Join the top pharmaceutical sponsors who have eliminated site initiation delays and audit risks. Book a demo to explore the platform.